The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Lobbes, M. B. I.; Prevos, R.; Smidt, M.; Tjan-Heijnen, V. C. G.; van Goethem, M.; Schipper, R.; Beets-Tan, R. G.; Wildberger, J. E.

doi:10.1007/s13244-013-0219-y

Cited by 237MRI in cancer diagnosisBreast Lesions and CarcinomasBreast Cancer Treatment Studies

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Open access

Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., Wildberger, J. E.·2013·Insights into Imaging

DOI 10.1007/s13244-013-0219-yPMC PMC3609956

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect pathologic complete response (pCR) after neoadjuvant chemotherapy for invasive breast cancer. METHODS: PubMed, the Cochrane Library, MEDLINE, and Embase databases were searched for relevant studies published until 1 July 2012. After primary selection, two reviewers independently assessed the content of each eligible study using a standardised extraction form and pre-defined inclusion and exclusion criteria. RESULTS: A total of 35 eligible studies were selected. Correlation coefficients of residual tumour size assessed by MRI and pathology were good, with a median value of 0.698. Reported sensitivity, specificity, positive predictive value and negative predictive value for predicting pCR with MRI ranged from 25 to 100 %, 50-97 %, 47-73 % and 71-100 %, respectively. Both overestimation and underestimation were observed. MRI proved more accurate in determining residual disease than physical examination, mammography and ultrasound. Diagnostic accuracy of MRI after neoadjuvant chemotherapy could be influenced by treatment regimen and breast cancer subtype. CONCLUSIONS: Breast MRI accuracy for assessing residual disease after neoadjuvant chemotherapy is good and surpasses other diagnostic means. However, both overestimation and underestimation of residual disease extent could be observed. MAIN MESSAGES: • Breast MRI accuracy for assessing residual disease is good and surpasses other diagnostic means. • Correlation coefficients of residual tumour size assessed by MRI and pathology were considered good. • However, both overestimation and underestimation of residual disease were observed. • Diagnostic accuracy of MRI seems to be affected by treatment regimen and breast cancer subtype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s13244-013-0219-y

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

MRI is superior to mammography and US in determining tumor extent and morphology before and after NAC.
“MRI is superior to mammography and US in determining tumor extent and morphology before and after NAC because it provides comprehensive imaging information about tumors (6).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [6]
The Introduction says MRI is superior to mammography and ultrasound for assessing tumour extent and additional foci; the Results and Discussion report better assessment of residual disease after NAC. The cited passages do not establish superiority for assessing tumour morphology before and after NAC, or give “comprehensive imaging information” as the reason for it. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965 · see citing works
Diagnostic Accuracy of Mammography, Clinical Examination, US, and MR Imaging in Preoperative Assessment of Breast Cancer
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,441 · see citing works
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D. N., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,196 · see citing works
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
Carney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K. M., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,144 · see citing works
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904 · see citing works
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL
Hylton, N. M., Blume, J. D., Bernreuter, W. K., Pisano, E. D., Rosen, M. A., Morris, E. A., Weatherall, P. T., Lehman, C. D., Newstead, G. M., Polin, S. M., et al. (2012) · Radiology · doi:10.1148/radiol.12110748 · Cited by 499 · see citing works
Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
Yeh, E. D., Slanetz, P. J., Kopans, D. B., Rafferty, E. A., Georgian-Smith, D., Moy, L. P., Halpern, E. F., Moore, R. H., Kuter, I., & Taghian, A. G. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 400 · see citing works
Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy
Partridge, S. C., Gibbs, J., Lü, Y., Esserman, L. J., Sudilovsky, D., & Hylton, N. M. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.5.1791193 · Cited by 337 · see citing works
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
Loo, C. E., Straver, M. E., Rodenhuis, S., Muller, S. H., Wesseling, J., Peeters, M.-J. T. F. D. V., & Gilhuijs, K. G. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1258 · Cited by 303 · see citing works
Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Park, S. H., Moon, W. K., Cho, N., Song, I. C., Chang, J. M., Park, I.-A., Han, W., & Noh, D. (2010) · Radiology · doi:10.1148/radiol.10092021 · Cited by 280 · see citing works
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients
Kong, X., Moran, M. S., Zhang, N., Haffty, B. G., & Yang, Q. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.014 · Cited by 265 · see citing works
Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant Chemotherapy
Chagpar, A. B., Middleton, L. P., Şahin, A. A., Dempsey, P. J., Buzdar, A. U., Mirza, A. N., Ames, F. C., Babiera, G. V., Feig, B. W., Hunt, K. K., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000197714.14318.6f · Cited by 246 · see citing works
Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging
Martincich, L., Montemurro, F., Rosa, G. D., Marra, V., Ponzone, R., Cirillo, S., Gatti, M., Biglia, N., Sarotto, I., Sismondi, P., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010700.11092.f4 · Cited by 238 · see citing works
Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria
Park, J. O. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg093 · Cited by 223 · see citing works
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
Rieber, A., Brambs, H., Gabelmann, A., Heilmann, V., Kreienberg, R., & Kühn, T. (2002) · European Radiology · doi:10.1007/s00330-001-1233-x · Cited by 216 · see citing works
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
Marinovich, M. L., Sardanelli, F., Ciatto, S., Mamounas, E. P., Brennan, M. E., Macaskill, P., Irwig, L., von Minckwitz, G., & Houssami, N. (2012) · The Breast · doi:10.1016/j.breast.2012.07.006 · Cited by 197 · see citing works
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
Chen, J., Feig, B., Agrawal, G., Yu, H. J., Carpenter, P. M., Mehta, R. S., Nalcioğlu, O., & Su, M. (2007) · Cancer · doi:10.1002/cncr.23130 · Cited by 181 · see citing works
MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer
Esserman, L. J., Kaplan, E., Partridge, S., Tripathy, D., Rugo, H. S., Park, J., Hwang, S. E., Kuerer, H. M., Sudilovsky, D., Lü, Y., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0549-8 · Cited by 170 · see citing works
Physiologic Changes in Breast Magnetic Resonance Imaging during the Menstrual Cycle: Perfusion Imaging, Signal Enhancement, and Influence of the T1 Relaxation Time of Breast Tissue
Delille, J.-P., Slanetz, P. J., Yeh, E. D., Kopans, D. B., & Garrido, L. (2005) · The Breast Journal · doi:10.1111/j.1075-122x.2005.21499.x · Cited by 165 · see citing works
Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imaging and Pathologic Findings
Woodhams, R., Kakita, S., Hata, H., Iwabuchi, K., Kuranami, M., Gautam, S., Hatabu, H., Kan, S., & Mountford, C. E. (2010) · Radiology · doi:10.1148/radiol.2542090405 · Cited by 158 · see citing works
Accuracy of MRI in Prediction of Pathologic Complete Remission in Breast Cancer After Preoperative Therapy: A Meta-Analysis
Yuan, Y., Chen, X., Liu, S., & Shen, K. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3908 · Cited by 151 · see citing works
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
Fangberget, A., Nilsen, L. B., Hole, K. H., Holmen, M. M., Engebraaten, O., Naume, B., Smith, H.-J., Olsen, D. R., & Seierstad, T. (2010) · European Radiology · doi:10.1007/s00330-010-2020-3 · Cited by 146 · see citing works
Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy
Schott, A. F., Roubidoux, M. A., Helvie, M. A., Hayes, D. F., Kleer, C. G., Newman, L. A., Pierce, L. J., Griffith, K. A., Murray, S., Hunt, K. A., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-2510-1 · Cited by 141 · see citing works
Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI
Cheung, Y., Chen, S.-C., Su, M., See, L., Hsueh, S., Chang, H., Lin, Y., & Tsai, C.-S. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1022153327339 · Cited by 132 · see citing works
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer
Denis, F., Desbiez-Bourcier, A. V., Chapiron, C., Arbion, F., Body, G., & Brunereau, L. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.07.024 · Cited by 123 · see citing works
Dynamic Contrast Enhanced Magnetic Resonance Imaging of the Breast Is Superior to Triple Assessment for the Pre-Operative Detection of Multifocal Breast Cancer
Drew, P. J., Chatterjee, S., Turnbull, L. W., Read, J., Carleton, P. J., Fox, J. N., Monson, J. R. T., & Kerin, M. J. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0599-x · Cited by 119 · see citing works
Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy
Shin, H. J., Kim, H. H., Ahn, J.-H., Kim, S.-B., Jung, K. H., Gong, G. Y., Son, B. H., & Ahn, S. H. (2011) · British Journal of Radiology · doi:10.1259/bjr/74430952 · Cited by 116 · see citing works
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Wu, L., Hu, J., Gu, H.-Y., Hua, J., Chen, J., & Xu, J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2033-5 · Cited by 114 · see citing works
The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast
Mann, R. M., Veltman, J., Barentsz, J. O., Wobbes, T., Blickman, J. G., & Boetes, C. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.04.020 · Cited by 113 · see citing works
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer
Park, S. H., Moon, W. K., Cho, N., Chang, J. M., Im, S., Park, I. A., Kang, K. W., Han, W., & Noh, D. (2011) · European Radiology · doi:10.1007/s00330-011-2236-x · Cited by 105 · see citing works
Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Segara, D., Krop, I. E., Garber, J. E., Winer, E. P., Harris, L. N., Bellon, J. R., Birdwell, R. L., Lester, S. C., Lipsitz, S. R., Iglehart, J. D., et al. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20856 · Cited by 100 · see citing works
MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy
Belli, P., Costantini, M., Malaspina, C., Magistrelli, A., Torre, G. L., & Bonomo, L. (2006) · Clinical Radiology · doi:10.1016/j.crad.2006.07.004 · Cited by 96 · see citing works
Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
Bhattacharyya, M., Ryan, D. P., Carpenter, R., Vinnicombe, S., & Gallagher, C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604171 · Cited by 95 · see citing works
Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer
Cowen, D. M., Houvenaeghel, G. F., Bardou, V., Jacquemier, J. D., Bautrant, É., Conte, M., Viens, P., Largillier, R., Puig, B., Resbeut, M., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00553-2 · Cited by 90 · see citing works
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?
Warren, R. M. L., Bobrow, L. G., Earl, H. M., Britton, P. D., Gopalan, D., Purushotham, A. D., Wishart, G. C., Benson, J. R., & Hollingworth, W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601710 · Cited by 89 · see citing works
Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: Relation to response patterns on MRI
Kim, H. J., Im, Y., Kim, H. J., Im, Y., Han, B., Choi, N., Lee, J., Kim, H. J., Choi, Y., Ahn, J., et al. (2007) · Acta Oncologica · doi:10.1080/02841860701373587 · Cited by 87 · see citing works
Breast Cancer: Evaluation of Response to Neoadjuvant Chemotherapy with 3.0-T MR Imaging
Chen, J., Bahri, S., Mehta, R. S., Kuzucan, A., Yu, H. J., Carpenter, P. M., Feig, S. A., Lin, M., Hsiang, D. J. B., Lane, K. T., et al. (2011) · Radiology · doi:10.1148/radiol.11110814 · Cited by 82 · see citing works
MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component
Goethem, M. V., Schelfout, K., Kersschot, E., Colpaert, C., Verslegers, I., Biltjes, I., Tjalma, W. A. A., de Schepper, A., Weyler, J., & Parizel, P. M. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.12.004 · Cited by 80 · see citing works
Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion‐weighted imaging and MRS
Shin, H. J., Baek, H., Ahn, J., Baek, S., Kim, H., Cha, J. H., & Kim, H. H. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2807 · Cited by 74 · see citing works
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas
Gimenez-Conti, I. B., Collet, A., Lanfranchi, H. E., Itoiz, M. E., Luna, M. A., Xu, H., Hu, S.-X., Benedict, W. F., & Conti, C. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960701)78:1 · Cited by 69 · see citing works
Why Do Purely Intraductal Cancers Enhance on Breast MR Images?
Kuhl, C. K. (2009) · Radiology · doi:10.1148/radiol.2532091401 · Cited by 68 · see citing works
Magnetic Resonance Imaging Patterns of Tumor Regression After Neoadjuvant Chemotherapy in Breast Cancer Patients
Kim, T. H., Kang, D. K., Yim, H., Jung, Y. S., Kim, K. S., & Kang, S. Y. (2012) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e318246abf3 · Cited by 67 · see citing works
MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant Chemotherapy
Straver, M. E., Loo, C. E., Rutgers, E. J. T., Oldenburg, H. S. A., Wesseling, J., Peeters, M.-J. T. F. D. V., & Gilhuijs, K. G. A. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181c5dda3 · Cited by 63 · see citing works
Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment
Moon, H., Han, W., Lee, J. W., Ko, E. S., Kim, E., Yu, J. H., Kang, S. Y., Moon, W. K., Cho, N., Park, I.-A., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn683 · Cited by 59 · see citing works
RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma
Therasse, P., Cesne, A. L., Glabbeke, M. M. V., Verweij, J., & Judson, I. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.005 · Cited by 58 · see citing works
MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes
Nakahara, H., Yasuda, Y., Machida, E., Maeda, Y., Furusawa, H., Komaki, K., Funagayama, M., Nakahara, M., Tamura, S., & Akiyama, F. (2010) · Breast Cancer · doi:10.1007/s12282-010-0235-4 · Cited by 42 · see citing works
Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy
Santos, J. D. L., Bernreuter, W. K., Keene, K. S., Krontiras, H., Carpenter, J. T., Bland, K. I., Cantor, A. B., & Forero, A. (2011) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.06.007 · Cited by 41 · see citing works
Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker Profile
Kuzucan, A., Chen, J., Bahri, S., Mehta, R. S., Carpenter, P. M., Fwu, P. T., Yu, H. J., Hsiang, D. J. B., Lane, K. T., Butler, J., et al. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2012.01.009 · Cited by 39 · see citing works
Optimal assessment of residual disease after neo‐adjuvant therapy for locally advanced and inflammatory breast cancer—clinical examination, mammography, or magnetic resonance imaging?
Wright, F. C., Zubovits, J. T., Gardner, S. L., Fitzgerald, B., Clemons, M. J., Quan, M. L., & Causer, P. A. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21559 · Cited by 37 · see citing works
Dynamic Breast Magnetic Resonance Imaging: Pretreatment Prediction of Tumor Response to Neoadjuvant Chemotherapy
Dong-feng, H., Ma, D., & Erhu, J. (2012) · Clinical Breast Cancer · doi:10.1016/j.clbc.2011.11.002 · Cited by 22 · see citing works
Computer-Aided Evaluation of Breast MRI for the Residual Tumor Extent and Response Monitoring in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Lyou, C. Y., Cho, N., Kim, S. M., Jang, M., Park, J.-S., Baek, S. Y., & Moon, W. K. (2011) · Korean Journal of Radiology · doi:10.3348/kjr.2011.12.1.34 · Cited by 22 · see citing works
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer
Guarneri, V., Pecchi, A., Piacentini, F., Barbieri, E., Dieci, M. V., Ficarra, G., Tazzioli, G., Frassoldati, A., Battista, R., Canossi, B., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1590-x · Cited by 21 · see citing works
Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy
Takeda, K., Kanao, S., Okada, T., Kataoka, M., Ueno, T., Toi, M., Ishiguro, H., Mikami, Y., & Togashi, K. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.12.013 · Cited by 16 · see citing works
MRI Evaluation of Pathologically Complete Response and Residual Tumors in Breast Cancer After Neoadjuvant Chemotherapy
Heywang-Köbrunner, S. H. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79247-1 · Cited by 11 · see citing works
Evaluation of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy
Wang, X., Peng, W., Tan, H., Xin, C., & Mao, J. (2010) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-010-0706-2 · Cited by 10 · see citing works
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer
Amodei, L. (2012) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2012.07.002 · Cited by 1 · see citing works

Flagged first, then by citations

Sorted by citations

Contrast-enhanced Mammography: State of the Art
Jochelson, M. S., & Lobbes, M. B. I. (2021) · Radiology · doi:10.1148/radiol.2021201948 · Cited by 353 · see citing works
Self-citation
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Hylton, N. M., Gatsonis, C. A., Rosen, M. A., Lehman, C. D., Newitt, D. C., Partridge, S. C., Bernreuter, W. K., Pisano, E. D., Morris, E. A., Weatherall, P. T., et al. (2015) · Radiology · doi:10.1148/radiol.2015150013 · Cited by 278 · see citing works
Imaging Neoadjuvant Therapy Response in Breast Cancer
Fowler, A. M., Mankoff, D. A., & Joe, B. N. (2017) · Radiology · doi:10.1148/radiol.2017170180 · Cited by 244 · see citing works
Quality indicators in breast cancer care: An update from the EUSOMA working group
Biganzoli, L., Marotti, L., Hart, C. D., Cataliotti, L., Cutuli, B., Kühn, T., Mansel, R. E., Ponti, A., Poortmans, P. M., Regitnig, P., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.017 · Cited by 216 · see citing works
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016
Liedtke, C., & Thill, M. (2016) · Breast Care · doi:10.1159/000446941 · Cited by 189 · see citing works
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
Huang, Y., Zhu, T., Zhang, X., Li, W., Zheng, X., Cheng, M., Ji, F., Zhang, L., Yang, C., Wu, Z., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.101899 · Cited by 175 · see citing works
Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
Iotti, V., Ravaioli, S., Vacondio, R., Coriani, C., Caffarri, S., Sghedoni, R., Nitrosi, A., Ragazzi, M., Gasparini, E., Masini, C., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0899-1 · Cited by 148 · see citing works
Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI
Tudorica, A., Oh, K. Y., Hui, J. Y. C., Roy, N. C., Troxell, M. L., Naik, A. M., Kemmer, K. A., Chen, Y., Holtorf, M. L., Afzal, A., et al. (2016) · Translational Oncology · doi:10.1016/j.tranon.2015.11.016 · Cited by 138 · see citing works
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Goorts, B., van Nijnatten, T. J. A., de Munck, L., Moossdorff, M., Heuts, E. M., de Boer, M., Lobbes, M. B. I., & Smidt, M. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4155-2 · Cited by 134 · see citing works
Self-citation
Role of Imaging in Neoadjuvant Therapy for Breast Cancer
Dialani, V. M., Chadashvili, T., & Slanetz, P. J. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4403-9 · Cited by 133 · see citing works
Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis
Gu, Y.-L., Pan, S.-M., Ren, J., Yang, Z.-X., & Jiang, G.-Q. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.12.010 · Cited by 128 · see citing works
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
Patel, B., Hilal, T., Covington, M. F., Zhang, N., Kosiorek, H., Lobbes, M. B. I., Northfelt, D., & Pockaj, B. A. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6413-x · Cited by 116 · see citing works
Self-citation
Contrast-enhanced Mammography: Current Applications and Future Directions
Ghaderi, K. F., Phillips, J., Perry, H., Lotfi, P., & Mehta, T. S. (2019) · Radiographics · doi:10.1148/rg.2019190079 · Cited by 115 · see citing works
Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy
Marinovich, M. L., Macaskill, P., Irwig, L., Sardanelli, F., von Minckwitz, G., Mamounas, E. P., Brennan, M. E., Ciatto, S., & Houssami, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.473 · Cited by 108 · see citing works
MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
Weber, J. J., Jochelson, M. S., Eaton, A. A., Zabor, E. C., Barrio, A. V., Gemignani, M. L., Pilewskie, M. L., Zee, K. J. V., Morrow, M., & El-Tamer, M. B. (2017) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.08.027 · Cited by 105 · see citing works
Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review
Granzier, R. W. Y., van Nijnatten, T. J. A., Woodruff, H. C., Smidt, M. L., & Lobbes, M. B. I. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108736 · Cited by 98 · see citing works
Self-citation
Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
Qu, Y., Zhu, H., Cao, K., Li, X., Ye, M., & Sun, Y. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13309 · Cited by 96 · see citing works
MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variability
Granzier, R. W. Y., Verbakel, N. M. H., Ibrahim, A., van Timmeren, J. E., van Nijnatten, T. J. A., Leijenaar, R. T. H., Lobbes, M. B. I., Smidt, M. L., & Woodruff, H. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70940-z · Cited by 88 · see citing works
Self-citation
Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer
Vriens, B. E. P. J., de Vries, B., Lobbes, M. B. I., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., de Boer, M., van Spronsen, D. J., Smidt, M. L., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.010 · Cited by 85 · see citing works
Self-citation
ACR Appropriateness Criteria ® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer
Slanetz, P. J., Moy, L. P., Baron, P. L., diFlorio‐Alexander, R. M., Green, E. D., Heller, S. L., Holbrook, A. I., Lee, S., Lewin, A. A., Lourenço, A. P., et al. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.08.037 · Cited by 83 · see citing works
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Goorts, B., Dreuning, K. M. A., Houwers, J. B., Kooreman, L. F. S., Boerma, E.-J. G., Mann, R. M., Lobbes, M. B. I., & Smidt, M. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0950-x · Cited by 83 · see citing works
Self-citation
Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
Prihantono, P., & Faruk, M. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102793 · Cited by 84 · see citing works
Proton MR spectroscopy in the breast: Technical innovations and clinical applications
Fardanesh, R., Marino, M. A., Avendaño, D., Leithner, D., Pinker, K., & Thakur, S. B. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26700 · Cited by 79 · see citing works
Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy
Kim, S.-Y., Cho, N., Park, I.-A., Kwon, B. R., Shin, S. U., Kim, S. Y., Lee, S. H., Chang, J. M., & Moon, W. K. (2018) · Radiology · doi:10.1148/radiol.2018172868 · Cited by 78 · see citing works
Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
Barra, F. R., Sobrinho, A. B., Barra, R. R., Magalhães, M. T., Aguiar, L. R., de Albuquerque, G. F. L., Costa, R. P., Farage, L., & Pratesi, R. (2018) · BioMed Research International · doi:10.1155/2018/8531916 · Cited by 75 · see citing works
Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response
Santamaría, G., Bargalló, X., Fernández, P. L., Farrus, B., Caparrós, X., & Velasco, M. (2016) · Radiology · doi:10.1148/radiol.2016160176 · Cited by 71 · see citing works
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Torrisi, R., Marrazzo, E., Agostinetto, E., Sanctis, R. D., Losurdo, A., Masci, G., Tinterri, C., & Santoro, A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103280 · Cited by 65 · see citing works
Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy
Aghaei, F., Tan, M., Hollingsworth, A. B., & Zheng, B. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25276 · Cited by 62 · see citing works
Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
Gentile, L. F., Plitas, G., Zabor, E. C., Stempel, M. M., Morrow, M., & Barrio, A. V. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6085-y · Cited by 62 · see citing works
Contrast-enhanced mammography: what the radiologist needs to know
Neeter, L. M. F. H., Raat, H., de Alcântara, R. C., Robbe, Q., Smidt, M. L., Wildberger, J. E., & Lobbes, M. B. I. (2021) · BJR|Open · doi:10.1259/bjro.20210034 · Cited by 59 · see citing works
Self-citation
Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
Bufi, E., Belli, P., Costantini, M., Cipriani, A., Matteo, M. D., Bonatesta, A., Franceschini, G., Terribile, D. A., Mulè, A., Nardone, L., et al. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.02.002 · Cited by 58 · see citing works
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial
Lee, H., Han, W., Kim, S., Cho, N., Kim, K.-E., Park, J. H., Ju, Y. W., Lee, E.-S., Lim, S.-J., Kim, J. H., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05678-3 · Cited by 57 · see citing works
Magnetic resonance imaging: The evolution of breast imaging
Heywang-Köbrunner, S. H., Hacker, A., & Sedlacek, S. (2013) · The Breast · doi:10.1016/j.breast.2013.07.014 · Cited by 54 · see citing works
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
Tan, W., Yang, M. W., Yang, H., Zhou, F., & Shen, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174435 · Cited by 49 · see citing works
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Che, S., Zhao, X., Ou, Y.-H., Li, J., Wang, M., Wu, B., & Zhou, C. (2016) · Medicine · doi:10.1097/md.0000000000002420 · Cited by 48 · see citing works
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
Bouzón, A., Nebril, B. A., Soler, R., Iglesias, Á., Santiago, P., Mosquera, J., Calvo, L., Seoane‐Pillado, T., & García, A. (2016) · Radiology and Oncology · doi:10.1515/raon-2016-0007 · Cited by 47 · see citing works
Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
Negrão, E. M. S., de Souza, J. A., Marques, E. F., & Bitencourt, A. G. V. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108701 · Cited by 47 · see citing works
A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
Mao, N., Dai, Y., Zhou, H., Lin, F., Zheng, T., Li, Z., Yang, P., Zhao, F., Li, Q., Wang, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1576 · Cited by 51 · see citing works
“MRI is superior to mammography and US in determining tumor extent and morphology before and after NAC because it provides comprehensive imaging information about tumors ( 6 ).”
The Way of the Future: Personalizing Treatment Plans Through Technology
Liefaard, M. C., Lips, E. H., Wesseling, J., Hylton, N. M., Lou, B., Mansi, T., & Pusztai, L. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_320593 · Cited by 46 · see citing works
Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour
Kim, S., Cho, N., Shin, S. U., Lee, H., Han, W., Park, I. A., Kwon, B. R., Kim, S., Lee, S. H., Chang, J. M., et al. (2018) · European Radiology · doi:10.1007/s00330-017-5251-8 · Cited by 43 · see citing works
Ultrasonography-Guided Surgical Clip Placement for Tumor Localization in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer
Youn, I., Choi, S. H., Kook, S. H., Choi, Y. J., Park, C. H., Park, Y. L., & Kim, D. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.1.44 · Cited by 42 · see citing works
Molecular imaging of breast cancer: present and future directions
Alcántara, D., Leal, M. P., GarcÃa-Bocanegra, I., & García‐Martín, M. L. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00112 · Cited by 43 · see citing works
Hybrid 18F–FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy
Goorts, B., Vöö, S. A., van Nijnatten, T. J. A., Kooreman, L. F. S., de Boer, M., Keymeulen, K., Aarnoutse, R., Wildberger, J. E., Mottaghy, F. M., Lobbes, M. B. I., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3745-x · Cited by 41 · see citing works
Self-citation
Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients
Cho, G. Y., Gennaro, L., Sutton, E. J., Zabor, E. C., Zhang, Z., Giri, D. D., Moy, L. P., Sodickson, D. K., Morris, E. A., Sigmund, E. E., et al. (2017) · European Journal of Radiology Open · doi:10.1016/j.ejro.2017.07.002 · Cited by 41 · see citing works
Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
Bufi, E., Belli, P., Matteo, M. D., Terribile, D. A., Franceschini, G., Nardone, L., Petrone, G., & Bonomo, L. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.05.002 · Cited by 40 · see citing works
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Granzier, R. W. Y., Ibrahim, A., Primakov, S. P., Samiei, S., van Nijnatten, T. J. A., de Boer, M., Heuts, E. M., Hulsmans, F. J., Chatterjee, A., Lambin, P., et al. (2021) · Cancers · doi:10.3390/cancers13102447 · Cited by 40 · see citing works
Self-citation
Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes
Kim, J., Han, B., Ko, E. Y., Ko, E. S., Choi, J. S., & Park, K. W. (2022) · European Radiology · doi:10.1007/s00330-021-08461-0 · Cited by 39 · see citing works
Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
An, Y. Y., Kim, S. H., Kang, B. J., & Lee, A. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.6.808 · Cited by 39 · see citing works
Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning
Rubio, I. T., & Sobrido, C. (2021) · The Breast · doi:10.1016/j.breast.2021.12.019 · Cited by 36 · see citing works
Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer
Huang, Y., Chen, W., Zhang, X., He, S., Shao, N., Shi, H., Lin, Z., Wu, X., Li, T., Lin, H., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.662749 · Cited by 35 · see citing works
Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study
Bernardi, D., Vatteroni, G., Acquaviva, A., Valentini, M., Sabatino, V., Bolengo, I., Pellegrini, M., Fantò, C., & Trimboli, R. M. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27756 · Cited by 35 · see citing works
Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm
Ha, R. S., Chang, P., Karcich, J., Mutasa, S., Sant, E. P. V., Connolly, E. P., Chin, C., Taback, B., Liu, M. Z., & Jambawalikar, S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6613-4 · Cited by 33 · see citing works
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
Virostko, J. M., Hainline, A. E., Kang, H., Arlinghaus, L. R., Abramson, R. G., Barnes, S. L., Blume, J. D., Avery, S., Patt, D. A., Goodgame, B. W., et al. (2017) · Journal of medical imaging · doi:10.1117/1.jmi.5.1.011011 · Cited by 30 · see citing works
ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update
Hayward, J. H., Linden, O. E., Lewin, A. A., Weinstein, S. P., Bachorik, A. E., Balija, T. M., Kuzmiak, C. M., Paulis, L. V., Salkowski, L. R., Sanford, M. F., et al. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.02.016 · Cited by 29 · see citing works
Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance
Choi, W. J., Kim, H. H., Cha, J. H., Shin, H. J., Chae, E. Y., & Yoon, G. Y. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.06.017 · Cited by 29 · see citing works
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype
Candelaria, R. P., Bassett, R. L., Symmans, W. F., Ramineni, M., Moulder, S. L., Kuerer, H. M., Thompson, A. M., & Yang, W. T. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0307 · Cited by 28 · see citing works
How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer
Price, E. R., Wong, J., Mukhtar, R. A., Hylton, N. M., & Esserman, L. J. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i7.607 · Cited by 27 · see citing works
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer
Charehbili, A., Wasser, M. N. J. M., Smit, V. T. H. B. M., Putter, H., van Leeuwen‐Stok, A. E., Kranenbarg, E. M., Liefers, G., van de Velde, C. J. �., Nortier, J. W. R., & Kroep, J. R. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.07.036 · Cited by 27 · see citing works
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
Al-Hattali, S., Vinnicombe, S., Gowdh, N. M., Evans, A. J., Armstrong, S., Adamson, D. J. A., Purdie, C. A., & Macaskill, E. J. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0279-4 · Cited by 27 · see citing works
Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging
Albano, D., Bruno, F., Agostini, A., Angileri, S. A., Benenati, M., Bicchierai, G., Cellina, M. I., Chianca, V., Cozzi, D., Danti, G., et al. (2021) · Japanese Journal of Radiology · doi:10.1007/s11604-021-01223-4 · Cited by 27 · see citing works
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
Li, W., Arasu, V. A., Newitt, D. N., Jones, E. F., Wilmes, L. J., Gibbs, J., Kornak, J., Joe, B. N., Esserman, L. J., & Hylton, N. (2016) · Tomography · doi:10.18383/j.tom.2016.00247 · Cited by 27 · see citing works
Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features
Choi, W. J., Kim, H. H., Cha, J. H., Shin, H. J., & Chae, E. Y. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.21016 · Cited by 27 · see citing works
Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer
Lin, X., Xu, R., Mao, S., Zhang, Y., Dai, Y., Guo, Q., Song, X., Zhang, Q., Li, L., & Chen, Q. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.34 · Cited by 27 · see citing works
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?
Özkurt, E., Sakai, T., Wong, S. M., Tükenmez, M., & Golshan, M. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07534-1 · Cited by 26 · see citing works
Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI
Moo, T.-A. S., Jochelson, M. S., Zabor, E. C., Stempel, M. M., Raiss, M., Mamtani, A., Tadros, A. B., El-Tamer, M. B., & Morrow, M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07867-x · Cited by 26 · see citing works
The Role of MRI in Breast Cancer and Breast Conservation Therapy
Washington, I. R., Palm, R. F., White, J. R., Rosenberg, S. A., & Ataya, D. K. (2024) · Cancers · doi:10.3390/cancers16112122 · Cited by 25 · see citing works
Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy
Hilal, T., Covington, M. F., Kosiorek, H., Zwart, C. M., Ocal, I. T., Pockaj, B. A., Northfelt, D., & Patel, B. (2018) · The Breast Journal · doi:10.1111/tbj.13101 · Cited by 25 · see citing works
Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature
Civil, Y. A., Jonker, L. W., Koerkamp, M. P. M. G., Duvivier, K. M., de Vries, R., Oei, A. L., Slotman, B. J., van der Velde, S., & van den Bongard, H. J. G. D. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13233-9 · Cited by 25 · see citing works
Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis
Ploumen, R. A. W., de Mooij, C. M., Gommers, S., Keymeulen, K., Smidt, M. L., & van Nijnatten, T. J. A. (2023) · European Radiology · doi:10.1007/s00330-023-09547-7 · Cited by 24 · see citing works
Self-citation
Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models
Lin, Y. Y., Wang, J., Li, M., Zhou, C., Hu, Y., Wang, M., & Zhang, X. (2024) · The Breast · doi:10.1016/j.breast.2024.103737 · Cited by 24 · see citing works
Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study
Barra, F. R., de Souza, F. F., Camelo, R. E. F. A., Ribeiro, A. C. D. O., & Farage, L. (2017) · Radiologia Brasileira · doi:10.1590/0100-3984.2016-0029 · Cited by 24 · see citing works
MRI Performance in Detecting pCR After Neoadjuvant Chemotherapy by Molecular Subtype of Breast Cancer
Yu, N., Leung, V. W. Y., & Meterissian, S. H. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05032-9 · Cited by 23 · see citing works
MRI predictors of tumor-positive margins after breast-conserving surgery
Bahl, M., Baker, J. A., Kinsey, E. N., & Ghate, S. V. (2019) · Clinical Imaging · doi:10.1016/j.clinimag.2019.05.006 · Cited by 21 · see citing works
Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
Molière, S., Oddou, I., Noblet, V., Veillon, F., & Mathelin, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-55820-5 · Cited by 21 · see citing works
Good correlation does not automatically imply good agreement: The trouble with comparing tumour size by breast MRI versus histopathology
Lobbes, M. B. I., & Nelemans, P. J. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.08.025 · Cited by 20 · see citing works
Self-citation
Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting
Panico, C., Ferrara, F., Woitek, R., D'Angelo, A. R., Paola, V. D., Bufi, E., Conti, M., Palma, S., Cicero, S. L., Cimino, G., et al. (2022) · Cancers · doi:10.3390/cancers14235786 · Cited by 20 · see citing works
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study
Gentile, D., Martorana, F., Karakatsanis, A., Caruso, F., Caruso, M., Castiglione, G., Grazia, A. D., Pane, F., Rizzo, A. G., Vigneri, P. G., et al. (2024) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2024.108732 · Cited by 20 · see citing works
Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors
Li, M., Xu, B., Shao, Y., Liu, H., Du, B., & Yuan, J. (2017) · The Breast Journal · doi:10.1111/tbj.12811 · Cited by 20 · see citing works
Clinical Breast Magnetic Resonance Imaging: Technique, Indications, and Future Applications
Greenwood, H. I., Freimanis, R. I., Carpentier, B. M., & Joe, B. N. (2017) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2017.07.002 · Cited by 20 · see citing works
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy
Parissenti, A. M., Guo, B., Pritzker, L. B., Pritzker, K. P. H., Wang, X., Zhu, M., Shepherd, L. E., & Trudeau, M. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3498-9 · Cited by 20 · see citing works
Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients
Hottat, N. A., Badr, D. A., Lecomte, S., Besse‐Hammer, T., Jani, J. C., & Cannie, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-27787-x · Cited by 19 · see citing works
Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements
Hottat, N. A., Badr, D. A., Lecomte, S., Besse‐Hammer, T., Jani, J. C., & Cannie, M. (2022) · European Radiology · doi:10.1007/s00330-021-08462-z · Cited by 18 · see citing works
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials
Graeser, M., Schrading, S., Gluz, O., Strobel, K., Herzog, C., Umutlu, L., Frydrychowicz, A. P., Rjosk-Dendorfer, D., Würstlein, R., Culemann, R., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01413-y · Cited by 18 · see citing works
Association of pharmacokinetic and metabolic parameters derived using simultaneous PET/MRI: Initial findings and impact on response evaluation in breast cancer
Jena, A., Taneja, S., Singh, A., Negi, P., Mehta, S. B., Ahuja, A., Singhal, M. K., & Sarin, R. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.013 · Cited by 18 · see citing works
Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI
Conti, M., Morciano, F., Bufi, E., D'Angelo, A. R., Panico, C., Paola, V. D., Gori, E., Russo, G., Cimino, G., Palma, S., et al. (2023) · Cancers · doi:10.3390/cancers15051439 · Cited by 17 · see citing works
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol
Civil, Y. A., Oei, A. L., Duvivier, K. M., Bijker, N., Meijnen, P., Donkers, L., Verheijen, S., van Kesteren, Z., Palacios, M. A., Schijf, L. J., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10910-6 · Cited by 17 · see citing works
Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
Iotti, V., Ragazzi, M., Besutti, G., Marchesi, V., Ravaioli, S., Falco, G., Coiro, S., Bisagni, A., Gasparini, E., Rossi, P. G., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030435 · Cited by 17 · see citing works
Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography
Murakami, R., Tani, H., Kumita, S., & Uchiyama, N. (2021) · Acta Radiologica Open · doi:10.1177/20584601211063746 · Cited by 16 · see citing works
ACR Appropriateness Criteria® Imaging of the Axilla
Le‐Petross, H. T., Slanetz, P. J., Lewin, A. A., Bao, J. J., Dibble, E. H., Golshan, M. A., Hayward, J. H., Kubicky, C. D., Leitch, A. M., Newell, M. S., et al. (2022) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2022.02.010 · Cited by 16 · see citing works
Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications
Zhou, J., Li, G., Sheng, F., Qiao, P., Zhang, H., & Xing, X.-D. (2015) · Acta Radiologica · doi:10.1177/0284185115597263 · Cited by 16 · see citing works
Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?
Thompson, B. M., Chala, L. F., Shimizu, C., Mano, M. S., Filassi, J. R., Geyer, F. C., Torres, U. S., de Mello, G. G. N., & Leite, C. D. C. (2021) · European Radiology · doi:10.1007/s00330-021-08290-1 · Cited by 16 · see citing works
Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging
Kaise, H., Shimizu, F., Akazawa, K., Hasegawa, Y., Horiguchi, J., Miura, D., Kohno, N., & Ishikawa, T. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2017.12.002 · Cited by 16 · see citing works
Contrast-Enhanced Mammography-Guided Biopsy: Preliminary Results of a Single-Center Retrospective Experience
Sammarra, M., Piccolo, C. L., Sarli, M., Stefanucci, R., Tommasiello, M., Orsaria, P., Altomare, V., & Zobel, B. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040933 · Cited by 15 · see citing works
Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? − RESPONDER trial
van Egdom, L. S. E., Lagendijk, M., Heijkoop, E., Koning, A. H. J., van Deurzen, C. H. M., Jager, A., van Lankeren, W., & Koppert, L. B. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.05.005 · Cited by 15 · see citing works
Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy
Kim, M. J., Kim, E., Park, S., Moon, H. J., Kim, S. U., & Park, B. (2014) · Acta Radiologica · doi:10.1177/0284185114548507 · Cited by 14 · see citing works
Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response
Santamaría, G., Bargalló, X., Ganau, S., Alonso, I., Muñoz-Mateu, M., Mollà, M., Fernandez, P. R., & Prat, A. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.06.009 · Cited by 14 · see citing works
Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
Woo, J., Ryu, J. M., Jung, S. M., Choi, H. J., Lee, S. K., Yu, J., Lee, J. E., Kim, S. W., Nam, S. J., & Chae, B. J. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.08.023 · Cited by 14 · see citing works
Outcome and Cost Effectiveness of Ultrasonographically Guided Surgical Clip Placement for Tumor Localization in Patients undergoing Neo-adjuvant Chemotherapy for Breast Cancer
Masroor, I., Zeeshan, S., Afzal, S., Sufian, S. N., Ali, M. I., Khan, S. M., & Ahmad, K. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8339 · Cited by 14 · see citing works
The evaluation of the delayed swollen breast in patients with a history of breast implants
Keane, G. C., Keane, A. M., Diederich, R., Kennard, K., Duncavage, E. J., & Myckatyn, T. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1174173 · Cited by 13 · see citing works
Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis
Ahmed, G. A., Baron, D. H., & Agrawal, A. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07566-6 · Cited by 13 · see citing works

ORIGINAL ARTICLE
(2012)
Evaluation of Post-Neoadjuvant Chemotherapy Pathologic Complete Response and Residual Tumor Size of Breast Cancer: Analysis on Accuracy of MRI and Affecting Factors
Ahn, H. S., An, Y. Y., Jeon, Y. W., Suh, Y. J., & Choi, H. J. (2021) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2020.0120
Cancer du sein traité par chimiothérapie néoadjuvante : évaluation du reliquat tumoral par l'IRM mammaire. [MRI evaluation of residual breast carcinoma after neoadjuvant chemotherapy]
Morvan, A., Korvin, B. D., Bouriel, C., Carsin, A., Tas, P., Bendavid, C., Dupré, P.-F., Kerbrat, P., Mesbah, H., Porée, P., et al. (2010) · HAL
Predicción de la enfermedad residual por resonancia mamaria luego de quimioterapia neoadyuvante en pacientes con cáncer de mama
Dalila Vidallé (1), M. E. L. (. (2023) · Anuario Fundación Dr. J.R. Villavicencio
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
Bouzón, A., Nebril, B. A., Soler, R., Iglesias, Á., Santiago, P., Mosquera, J., Calvo, L., Seoane‐Pillado, T., & García, A. (2016) · Radiology and Oncology · doi:10.1515/raon-2016-0007 · Cited by 47 · see citing works

Authors: Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., & Wildberger, J. E.
Affiliations: Maastricht University Medical Centre (NL)
Corresponding author: Lobbes, M. B. I.
ORCID: Lobbes, M. B. I.
Smidt, M.
Schipper, R.
Wildberger, J. E.
Venue: Insights into Imaging
Publisher: Springer Science and Business Media LLC
Published: 2013-01-29
Volume: 4
Issue: 2
Pages: 163-175
ISSN: 1869-4101 (ISSN-L)
DOI: 10.1007/s13244-013-0219-y
PMC: PMC3609956
OpenAlex: W2057016707
Cited by: 237
References: 56
Citations by year: 2026: 10 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 22 · 2021: 25 · 2020: 15 · 2019: 23 · 2018: 16 · 2017: 24 · 2016: 16 · 2015: 11 · 2014: 8 · 2013: 4
FWCI: 1.84
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by-nc/2.0 (unspecified)
Locations: Insights into Imaging (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, cc-by)
Research Publications (Maastricht University) (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: breast MRI, residual disease, pathological complete response, neoadjuvant chemotherapy, invasive breast cancer, diagnostic accuracy, breast cancer subtypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks